Sermaise, France

Sebastien Roy

This inventor holds 1 USPTO granted patent. Top assignee: Principia Biopharma Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sebastien Roy. Retrieved from https://idiyas.com/inventor/sebastien-roy-xp6s1jqk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sebastien Roy: Inventor in Pharmaceutical Research.

Introduction

Sebastien Roy is an inventor associated with Sermaise, France, and Principia Biopharma Inc. His patent work concerns a class of chemical compounds described for potential use as agonists and antagonists.

Latest Patents

Roy is named on 1 patent: “4-amino-3-(4-phenoxyphenyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one derivatives and salts thereof.” The disclosure covers variants and derivatives of these compounds, their salts, compositions containing them, methods for preparing them, and methods of treatment.

Career Highlights

Roy’s listed patent reflects work in pharmaceutical innovation, particularly the development of compounds with potential therapeutic applications. The available information identifies Principia Biopharma Inc. as the company with which he is associated.

Collaborations

Catherine Arabeyre and Patricia Moliner are identified as Roy’s coworkers. Their names are also associated with the collaborative context of his patent work.

Conclusion

Sebastien Roy’s recorded invention focuses on pharmaceutical compounds and their potential uses, making his patent contribution part of research into therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…